Direct subunit-dependent multimodal 5-hydroxytryptamine 3 receptor antagonism by methadone

Molecular Pharmacology

Volumn 75, Issue 4, 2009, Pages 908-917

  Deeb, Tarek Z ^a   Sharp, Douglas ^a   Hales, Tim G ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; METHADONE; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DESENSITIZATION; DRUG ANTAGONISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BLOCKING; STEREOISOMERISM; STEREOSPECIFICITY;

CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METHADONE; MORPHINE; PROTEIN SUBUNITS; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; STEREOISOMERISM;

EID: 63849116222     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.053322     Document Type: Article

References (40)

1. A receptors of clonal murine hypothalamic GT1-7 neurones by propofol. Br J Pharmacol 115:953-960.
2. 3 receptor. Psychopharmacology (Berl) 158:18-27.
3. 3a receptors: probable involvement of an allosteric modulatory site. Br J Pharmacol 137:589-596.
4. 3 receptor - the relationship between structure and function. Neuropharmacology 56:273-284.
5. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PP, Middlemiss DN, Mylecharane EJ, Richardson BP, and Saxena PR (1986) Proposals for the classification and nomenclature offunctional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563-576.
6. Callahan RJ, Au JD, Paul M, Liu C, and Yost CS (2004) Functional inhibition by methadone of N-methyl-d-aspartate receptors expressed in Xenopus oocytes: ste- reospecific and subunit effects. Anesth Analg 98:653-659.
7. Carr DB and Cousins MJ (1998) Spinal route of analgesia: opioids and future options, in Neural Blockade in Clinical Anesthesia and Management of Pain (Cousins MJ and Bridenbaugh PO eds), pp. 915-984, Lippincott Williams & Wilkins, Baltimore, MD.
8. Das P and Dillon GH (2005) Molecular determinants of picrotoxin inhibition of 5-hydroxytryptamine type 3 receptors. J Pharmacol Exp Ther 314:320-328.
9. 3b subunit is a major determinant of serotonin-receptor function. Nature 397:359-363.
10. 3 receptors. J Biol Chem 283:9659-9665
11. 3B receptor subunit. J Biol Chem 274:30799-30810.
12. Eap CB, Crettol S, Rougier JS, Schlapfer J, Sintra Grilo L, Déglon JJ, Besson J, Croquette-Krokar M, Carrupt PA, and Abriel H (2007) Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther 81:719-728.
13. Ebert B, Andersen S, and Krogsgaard-Larsen P (1995) Ketobemidone, methadone and pethidine are non-competitive N-methyl-d-aspartate (NMDA) antagonists in the rat cortex and spinal cord. Neurosci Lett 187:165-168.
14. Fan P (1995) Nonopioid mechanism of morphine modulation of the activation of 5-hydroxytryptamine type 3 receptors. Mol Pharmacol 47:491-495.
15. Gaddum JH and Picarelli ZP (1957) Two kinds of tryptamine receptor. Br J Pharmacol 12:323-328.
16. Galligan JJ (2002) Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil 14:611-623.
17. Harlan RE and Garcia MM (1999) Brain regions and drug addiction. Science 284:1124 -1125.
18. 3 receptor. J Biol Chem 283:6826-6831.
19. 2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci 56:45-49.
20. + currents. J Pharmacol Exp Ther 303:688-694.
21. 3 receptor-mediated ion current in N1E-115 neuroblastoma cells. Br J Pharmacol 108:287-289.
22. Kranzler HR, Pierucci-Lagha A, Feinn R, and Hernandez-Avila C (2003) Effects of ondansetron in early-versus late-onset alcoholics: a prospective, open-label study. Alcohol Clin Exp Res 27:1150-1155.
23. Lew MJ and Angus JA (1995) Analysis of competitive agonist-antagonist interactions by nonlinear regression. Trends Pharmacol Sci 16:328-337.
24. 3 receptors synthesized in the rat CNS and peripheral nervous system. J Neurosci 22:6732-6741.
25. Niesler B, Frank B, Kapeller J, and Rappold GA (2003) Cloning, physical mapping and expression analysis of the human 5-HT3 serotonin receptor-like genes HTR3C, HTR3D and HTR3E. Gene 310:101-111.
26. Pakkanen JS, Nousiainen H, Yli-Kauhaluoma J, Kylainlahti I, Moiykkynen T, Korpi ER, Peng JH, Lukas RJ, Ahtee L, and Tuominen RK (2005) Methadone increases intracellular calcium in SH-SY5Y and SH-EP1-halpha7 cells by activating neuronal nicotinic acetylcholine receptors. J Neurochem 94:1329 -1341.
27. 3 receptor. Trends Pharmacol Sci 26:587-594.
28. 3 receptor mediated currents in murine N1E-115 neuroblastoma cells by ( + )-tubocurarine. Neurosci Lett 110:107-112.
29. 3B receptor subunits by anti-peptide polyclonal antibodies. BMC Neurosci 7:27.
30. Rodriguez-Martin I, Braksator E, Bailey CP, Goodchild S, Marrion NV, Kelly E, and Henderson G (2008) Methadone: does it really have low efficacy at μ-opioid receptors? Neuroreport 19:589-593.
31. 3 receptors native to neuroblastoma cells. Neuropharmacology 44:214-223.
32. 3 receptors in rat amygdala. Neuron 8:199-203.
33. 3 receptor antagonist, slows colonic transit in healthy man. Dig Dis Sci 35:477-480.
34. 3 receptors. Curr Pharm Des 12:3615-3630.
35. Tzvetkov MV, Meineke C, Oetjen E, Hirsch-Ernst K, and Brockmoller J (2007) Tissue-specific alternative promoters of the serotonin receptor gene HTR3B in human brain and intestine. Gene 386:52-62.
36. 3 receptors. Neuropharmacology 37:259-264.
37. 3 receptors in the CNS: 3B or not 3B? Trends Pharmacol Sci 24:157-160.
38. 3A receptors. Anesth Analg 103:747-752.
39. Xiao Y, Smith RD, Caruso FS, and Kellar KJ (2001) Blockade of rat α3β4 nicotinic receptor function by methadone, its metabolites, and structural analogs. J Pharmacol Exp Ther 299:366-371.
40. 3 receptor antagonist and its applications in CNS-related disorders. CNS Drug Rev 7:199-213.